CNBC -- critique. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : CNBC -- critique.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ted David who wrote (3046)	6/26/1999 12:28:00 PM
From: capitalistbeatnik	Read Replies (1) of 17683

I guess CNBC didn't consider it important to mention this in their Laser Vision report: The Federal Trade Commission said administrative law judge Stuart Levin dismissed FTC charges that Visx (VISX: news, msgs), one of the first companies to develop laser eye surgery equipment and technology known as photorefractive keratectomy, acquired a key patent by inequitable conduct and fraud by omission. The charges against Visx stem from a March 1998 complaint that alleged Summit Technology, Inc.(BEAM: news, msgs) and Visx, the only two companies legally able to market equipment for photorefractive keratectomy, placed their competing patents in a patent pool and shared the proceeds each time a Summit or Visx laser was used, violating antitrust laws, the FTC also said. Levin's initial decision ordering the dismissal of the remaining charges against Visx said that the FTC failed to make a case against those patents. See text of decision. Instead, it was something about looming concerns about enforceability of patents. Nice going CNBC. This is the state of American financial journalism. Somebody there should get run.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next